KRRO - Korro Bio, Inc.

QQQ $ 464.61 $ 1.87 (0.4 %)

DIA $ 389.34 $ 0.80 (0.21 %)

SPY $ 535.72 $ 1.65 (0.31 %)

TLT $ 90.89 $ -0.61 (-0.67 %)

GLD $ 213.56 $ 1.94 (0.92 %)

Previous Close

$ 46.99

Open

$ 46.51

Bid

$ 46.81 x 100

Ask

$ 0.00 x 0

Day's Range

$ 46.28 - $ 48.81

52 Week Range

$ 0.18 - $ 97.91

Volume

58,563

Average Volume

Market Cap

376.84M

Beta (5Y Monthly)

$ 8.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-26-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-10-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-15-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-29-2021	12-31-2020	10-K
15	11-16-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q
17	05-14-2020	03-31-2020	10-Q
18	03-26-2020	12-31-2019	10-K
19	11-18-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Korr...
05/21/2024 10:36:32

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Presents Additional Preclinical Data...
05/20/2024 18:33:01

KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels ...

HC Wainwright & Co. Maintains Buy on Korro...
05/15/2024 15:11:37

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target fro...

BMO Capital Maintains Outperform on Korro ...
05/15/2024 13:02:21

BMO Capital analyst Kostas Biliouris maintains Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $120 price target.

Korro Bio Q1 2024 Adj EPS $(2.44) Beats $(...
05/14/2024 20:20:30

Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.51) by ...

Korro Announces $70M Private Placement
04/18/2024 12:32:40

Financing led by Deep Track Capital with participation from other leading healthcare investorsPro-forma cash and cash equivalen...

HC Wainwright & Co. Maintains Buy on Korro...
03/28/2024 10:24:42

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and raises the price target fro...

Piper Sandler Maintains Overweight on Korr...
03/27/2024 16:46:12

Piper Sandler analyst Yasmeen Rahimi maintains Korro Bio (NASDAQ:KRRO) with a Overweight and maintains $180 price target.

RBC Capital Maintains Outperform on Korro ...
03/27/2024 14:38:00

RBC Capital analyst Luca Issi maintains Korro Bio (NASDAQ:KRRO) with a Outperform and raises the price target from $70 to $90.

Korro FY23 EPS $(53.08) Vs $(227.42) YoY
03/26/2024 20:16:38

Full Year 2023 Financial Results:Cash Position: Cash, cash equivalents and short-term investments were $166.1 million as of Dec...

BMO Capital Reiterates Outperform on Korro...
03/26/2024 11:48:08

BMO Capital analyst Kostas Biliouris reiterates Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $120 price target.

RBC Capital Reiterates Outperform on Korro...
03/12/2024 15:21:34

RBC Capital analyst Luca Issi reiterates Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $70 price target.

BMO Capital Initiates Coverage On Korro Bi...
02/27/2024 10:47:10

BMO Capital analyst Kostas Biliouris initiates coverage on Korro Bio (NASDAQ:KRRO) with a Outperform rating and announces Pr...

Ecolab Posts Strong Results, Joins Masonit...
02/13/2024 15:09:30

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

HC Wainwright & Co. Reiterates Buy on Korr...
01/19/2024 11:35:39

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Bio Highlights Data For Its Lead Pro...
01/18/2024 13:12:32

KRRO-110 has a potentially best-in-class profile with secretion of ~50µM functional AAT protein after a single dose in a precli...

Korro Announces Selection Of Its First Dev...
12/07/2023 13:10:37

KRRO-110 is the first RNA editing oligonucleotide candidate from Korro's proprietary OPERA™ platform Korro has demonstrated...

why-newly-listed-korro-bio-shares-are-gaining-today

Why Newly Listed Korro Bio Shares Are Gain...
12/04/2023 19:34:25

H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on e...

HC Wainwright & Co. Initiates Coverage On ...
12/04/2023 11:50:48

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and announce...

RBC Capital Initiates Coverage On Korro Bi...
11/29/2023 11:03:35

RBC Capital analyst Luca Issi initiates coverage on Korro Bio (NASDAQ:KRRO) with a Outperform rating and announces Price Tar...

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

KRROKorro Bio, Inc.

Nasdaq www.korrobio.com

$ 47.23 $ 0.59 (1.27 %)

Monday, 10-Jun-2024 15:58:48 EDT